SEP
ELV icon

Signature Equity Partners’s Elevance Health ELV Stock Holding History

Signature Equity Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.5K Buy
102
+33
+48% +$12.2K 0.02% 481
2026
Q1 		$20.2K Sell
69
-4
-5% -$1.31K 0.01% 631
2025
Q4 		$25.6K Buy
+73
New +$24.7K 0.01% 569

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Signature Equity Partners's ELV Position: Q2 2026 in Review

Signature Equity Partners increased its Elevance Health (ELV) stake by 48% in Q2 2026, buying an estimated $12.2K and bringing the position to 102 shares worth $39.5K. The position accounts for 0.02% of the portfolio, ranked #481.

Signature Equity Partners first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Signature Equity Partners held 102 shares of Elevance Health worth $39.5K as of Q2 2026.
  • Signature Equity Partners bought 33 Elevance Health shares in Q2 2026, an estimated $12.2K.
  • Elevance Health made up 0.02% of Signature Equity Partners's portfolio in Q2 2026, its #481 holding.
  • Signature Equity Partners first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.